[Scientific communication to "my" patient].

In scientific communication, "my" patient should be differentiated from the "average" patient of randomized controlled clinical trials. Communication addressed to "my" patient takes place in the delicate and a certain sense intimate doctor-patient relationship in which various components are involved, such as the patient's expectations, needs and hopes, the professional, emotional and bureaucratic fatigue of the doctor, scientist's rigor and superficiality, the administrator's economic and organizational sustainability, social, media and judicial control. The simple trust required in the era of "paternalism" has undergone a transition first into "informed consent" and then into "shared decision-making". The next step would be that of physicians implementing corporate protocols and guidelines or artificial intelligence algorithms, forgetting that medicine is science applied with art to a complex and complicated system that needs to be ruled by those who know it. Until more effective solutions are found, the most cost-effective way is to apply shared guidelines of evidence-based medicine free from weak recommendations based on expert consensus, asking scientists to "recommend not recommending" when uncertainty prevails, leaving the choice to doctor's experience and patient's preferences.